Molecular Imaging/ Nuclear Medicine
-
Upload
brucelee55 -
Category
Documents
-
view
705 -
download
3
Transcript of Molecular Imaging/ Nuclear Medicine
Radiological Society of North America95th Scientific Assembly and Annual MeetingNovember 29–December 4, 2009McCormick Place, Chicago
RSNA2009.RSNA.org
Molecular Imaging/Nuclear Medicine
SUBSPECIALTY CONTENT BROCHURE
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 1
Subspecialty content brochures organize the components of
the annual meeting by subjects that correspond to radiologic
subspecialties. We hope this brochure, along with the
Meeting Program, helps to enrich and ease your experience
at RSNA 2009.
RSNA Annual Meeting CME Information
RSNA® is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.
RSNA designates this educational activity for a maximum of
90.75 AMA PRA Category 1 Credits™. Physicians should only
claim credit commensurate with the extent of their
participation in the activity.
indicates a course being offered as a self-assessment
module (SAM).
Sunday, November 29, 2009
10:45-12:15 Scientific Paper SessionsISP: Molecular Imaging (Applications I) (SessionSSA12) (S504CD)
Nuclear Medicine (PET/CT in Oncology) (SessionSSA18) (S505AB)
2:00-3:30 Refresher CoursesEssentials of Molecular Imaging and SystemsDiagnostics for Clinical Radiologists (Course RC117)(E352)
PET Brain Imaging: Current and EmergingApplications—Emphasis on Dementia (Course RC111)(N228)
Monday, November 30, 2009
8:30-10:00 Refresher CoursesImproving Your PET Practice: Lessons Learned inClinical Practice, with Emphasis on Case Studies,Image Correlation, and PET/CT(An InteractiveSession) (Course RC211) (S103AB)
Oncologic Imaging in the Era of Molecular Medicine(Course RC217) (S503AB)
UpdateCourse in Diagnostic Radiology Physics:Imaging Technologies in Oncology—Imaging LungCancer (Course RC221) (S504AB)
S
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 2
8:30-12:00 Multisession CourseBreast/Nuclear Medicine/Molecular Imaging Series:Breast Imaging in the Era of Molecular Medicine(Course VM21) (Arie Crown Theater)
10:30-12:00 Scientific Paper SessionsISP: Nuclear Medicine (PET/CT of Lymphoma andOther Neoplasms) (Session SSC14) (S505AB)
Molecular Imaging (Multimodality) (Session SSC09)(S504CD)
1:30-5:45 Plenary SessionPhysics Symposium: Therapy Shielding and Physicsand Applications of PET/CT (Session PS52) (S104A)
3:00-4:00 Scientific Paper SessionsISP: Molecular Imaging (Ultrasound) (Session SSE13)(S504CD)
Nuclear Medicine (Imaging the Brain: Structure andFunction) (Session SSE19) (S505AB)
Tuesday, December 1, 2009
8:30-10:00 Multisession CourseMolecular Imaging: Here to Stay(Sponsored by theAssociated Sciences Consortium) (Course AS31)(E350)
Refresher CoursesNeurologic Imaging in the Era of Molecular Medicine(Course RC317) (N229)
PET for Assessing Treatment Response (CourseRC311) (N226)
Update Course in Diagnostic Radiology: Cardiac—Evaluation of Ischemia with CT, MR, and NuclearImaging (Course RC303) (N228)
10:30-12:00 Scientific Paper SessionsMolecular Imaging (Applications II) (Session SSG11)(S504CD)
Nuclear Medicine (PET/CT of GastrointestinalMalignancies) (Session SSG16) (S505AB)
1:30-2:45 Plenary SessionAnnual Oration in Diagnostic Radiology and GoldMedal Awards (Session PS60) (Arie Crown Theater)
3:00-4:00 Scientific Paper SessionsISP: Molecular Imaging (Cell Tracking) (SessionSSJ13) (S504CD)
Nuclear Medicine (General Nuclear Medicine: Part 1)(Session SSJ19) (S505AB)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 3
4:30-6:00 Refresher CoursesAdvances and Updates in Gastrointestinal andGenitourinary Nuclear Medicine (Course RC411)(S503AB)
Cardiovascular Imaging in the Era of MolecularMedicine (Course RC417) (E353A)
Challenges in Diagnosis and Management of theSolid Renal Mass (Course RC407) (E351)
Wednesday, December 2, 2009
8:30-10:00 Multisession CourseMolecular Imaging: Overview and Basics (CourseMI41) (S406B)
Refresher CoursesImaging the Postoperative Urinary Tract (CourseRC507) (S504AB)
Radionuclide Imaging of Inflammation and Infection:AMultimodality Approach (Course RC511) (E351)
10:30-12:00 Multisession CourseMolecular Imaging in Oncology (Course MI42)(S406B)
Scientific Paper SessionISP: Nuclear Medicine (Clinical Utility of QuantitativeImaging) (Session SSK16) (S505AB)
1:30-2:45 Multisession CourseMolecular Imaging in Cardiovascular Disease (CourseMI43) (S406B)
3:00-4:00 Scientific Paper SessionNuclear Medicine (General: Part 2) (Session SSM18)(S505AB)
3:15-4:45 Multisession CourseMolecular Imaging in Brain Disorders (Course MI44)(S406B)
4:30-6:00 Focus SessionIs PET a Reliable Indicator of Tumor Viability in theHead and Neck? (Session SFN03) (S404AB)
Thursday, December 3, 2009
8:30-10:00 Multisession CoursesCase-based Review of Nuclear Medicine: PET/CTWorkshop—Head and Neck Cancers (In ConjunctionwithSNM) (Course CC51) (E353B)
Refresher CoursesInterventional Radiology in the Era of MolecularMedicine (Course RC617) (E353A)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 4
Minicourse: Innovations and Advances in MedicalImaging Technology—ACR Accreditation of SPECTand PET (Course RC623) (S504CD)
Update Course in Diagnostic Radiology: Cardiac—New Developments in SPECT and PET of the Heart(Course RC603) (S103CD)
10:30-12:00 Multisession CoursesCase-based Review of Nuclear Medicine: PET/CTWorkshop—Cancers of the Thorax (In ConjunctionwithSNM) (Course CC52) (E353B)
Essentials of Nuclear Medicine (Course ES52)(S406B)
Scientific Paper SessionsISP: Nuclear Medicine (Endocrine andNeuroendocrine Imaging) (Session SSQ15)(S505AB)
Molecular Imaging (Applications III) (Session SSQ11)(S504CD)
1:30-3:00 Multisession CourseCase-based Review of Nuclear Medicine: PET/CTWorkshop—Cancers of the Abdomen and Pelvis (InConjunction withSNM) (Course CC53) (E353B)
3:00-4:00 Focus SessionSUVs in PET Imaging: A Blessing and a Curse(Session SFS08) (S404AB)
3:30-5:00 Multisession CourseCase-based Review of Nuclear Medicine: PET/CTWorkshop—Sarcoma/Melanoma/Lymphoma (InConjunction withSNM) (Course CC54) (E353B)
4:30-6:00 Refresher CourseGenitourinary Imaging in the Era of MolecularMedicine (Course RC717) (S404CD)
Friday, December 4, 2009
8:30-10:00 Refresher CoursesAdvances in Cardiac Nuclear Imaging: SPECT/CTand PET/CT (Course RC811) (S503AB)
Gastrointestinal Imaging in the Era of MolecularMedicine (Course RC817) (S404CD)
10:30-12:00 Scientific Paper SessionsGastrointestinal (Oncology: MR, CT, and PETImaging) (Session SST05) (E353C)
Nuclear Medicine (PET/CT of Neckand ChestMalignancies) (Session SST12) (S505AB)
Physics (PET and SPECT) (Session SST14) (S403B)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 5
Education ExhibitsCME is available when the author is present for discussion during thelunch period. Days are listed in parentheses.
Space No. Title
LL-ED0009 Nuclear Medicine Case of the Day Exhibit
LL-MI2301 Functional Tumoral Imaging Made Easy
LL-MI2302 Neuroendocrine Tumors Revisited: The Role ofMultimodality Imaging with Somatostatin ReceptorScintigraphy (SRS) and GLUT Receptor Imagingwith FDG PET/CT
LL-MI2303 Stem Cell Tracking with MR Imaging and OpticalImaging
LL-MI2304 Molecular Imaging Using Lipid-based Nanoprobesfor MRI
LL-MI2305 Nanotechnology's BigPromise for Radiology: A Byte-sized Conceptual Review of the Science of the Small
LL-MI3010 Principle of Molecular Imaging Using Nano-GoldLabeled Molecules and Tuned k-edge ComputedTomography
LL-MI3011-D A Radiologist’s Primer on Molecular and FunctionalImaging of Cancer: From Neovascularization to theNucleus (Monday)
LL-MI3012-H How to Measure Neurotransmitters with MRS andPET: Focus on GABA, Glutamate, and Dopamine(Tuesday)
LL-MS2528 CT, PET/CT, and MRI Findings of Tyrosine KinaseReceptor Inhibitor Cancer Therapies: Expected andUnexpected Radiographic Patterns of Response
LL-NM2306 False Positive Activity on Postthyroidectomy I-131Whole Body Scintigraphy: A Review andPresentation of Novel Techniques
LL-NM2307 Pitfalls in the Interpretation of Interval Changes inSuccessive Whole Body Bone Scintigrams: LessonsLearned from a Prospective Clinical Study
LL-NM2308 F18-FDG PET/CT Findings of UncommonHepatobiliary/Liver Tumors
LL-NM2309 Illustrative Review of the Radionuclide Manifestationsand Complications of Sickle Cell Anaemia
LL-NM2310 New Role of Sentinel Node Mapping Using 3DSEPCT-CT Fusion Imaging in Oral Cavity Cancer
LL-NM2311 Tc-99m MDP BoneScan Findings: Correlation withMRI and CT
LL-NM2312 Nuclear Neuropsychiatric Imaging: What RadiologyResidents Need to Know
LL-NM2313-H07 Update on Diagnostic Accuracy of V/Q Scan for theDiagnosis of Pulmonary Embolism (Tuesday)
LL-NM2314 Potential Role of Dedicated Multislice SPECT-CT inOncology
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 6
LL-NM2315 Role of Dedicated Multislice SPECT-CT Imaging inOrthopaedics
LL-NM2316 One of These Things Is Not Like the Other: Utility ofPattern Recognition in the Detection of UnsuspectedAdditional Primary Malignancies on PET-CT
LL-NM2317 PET-CT in the Evaluation and Management ofUnique and Uncommon Pediatric Malignancies
LL-NM2318 The Updated Imaging Diagnosis of MalignantLymphoma Based on WHO Classification
LL-NM2319 'New' Metastatic Disease Diagnosed on 18-FDGPET/CT: Should It Have Been Identified on PreviousStaging Imaging?
LL-NM2320-D07 PET/CT in the Evaluation of the Stomach,Duodenum, and Small Bowel (Monday)
LL-NM2321 Clinical Value of FDG-PET in Pediatric Oncology
LL-NM2322 Clinical Application of F-18 FLT PET for theEvaluation of Lung Diseases
LL-NM2323 Extranodal Lymphoma: Spectrum of PET/CTFindings
LL-NM2324 PET of Pediatric Bone DiseaseUsingF18 SodiumFluoride (NaF)
LL-NM2325 UnconventionalFluorodeoxyglucose (FDG) AvidDisease Entities and Unexpected Patterns of FDGAvidity Seen in Malignant Diseases Utilizing FDGPET-CT: A Pictorial Essay
LL-NM2326-H06 Seizure Diagnosis Using Multimodality Imaging ofMEG, MRI, PET, and SPECT (Tuesday)
LL-NM2327 The Role of Diagnostic Contrast-enhanced PET/CTin Intensity-modulated Radiation Therapy Planning:Usefulness and Limitations with Emphasis on Headand Neck Malignancies
LL-NM2328 Pancreatic Cancer: Evaluation with 18F-FDGPET/CT—A Pictorial Review
LL-NM2329 The Standardized Uptake Value in FDG PET Imaging:Challenges in Acquisition and Application
LL-NM2330 Assessment of Immediate Therapeutic Response toRadiofrequency Ablation and Surveillance ofRecurrence in Neoplastic Lesions: Demonstrationwith FDG PET-CT
LL-NM2331 The Role of FDG-PET in the Diagnosis, Staging, andTreatment Response in Patients with PosttransplantLymphoproliferative Disorder
LL-NM2332-L07 Management of Differentiated Thyroid Cancer:Emphasis on the Role of Imaging and RadioiodineTherapy (Wednesday)
LL-NM2333 How Much 131-I Should We Use to Treat Grave’sHyperthyroidism? As Well as: How to Handle PatientWork-up, Patient Dosing, and Follow-up
LL-NM2334-R07 Radioiodine Therapy for Benign Thyroid Disease(Thursday)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 7
LL-NM3101 FDG PET/CT Scan in Oral and OropharyngealCancers: Role in Staging and Restaging, PathologicalPatterns, Pearls and Pitfalls, Rare, and FrequentNormal Variants
LL-NM3102 Benign, Ambiguous, and Malignant MusculoskeletalLesions: F-18 FDG PET/CT Imaging
LL-NM3103 E-NUCS: Online Evaluation and Skills Developmentin Nuclear Medicine with a Focus on HybridModalities such as PET/CT and SPECT/CT
LL-NM3104 Imaging Lymphoma Involvement of the PeripheralNervous System
LL-NM3105 Back Pain after Spinal Surgery:Can Bone SPECT-CT Pin the Cause? A Preliminary Experience
LL-NM3106 Iodine SPECT-CT: Is There a Point?
LL-NM3107-H Current SPECT/CT Hybrid Technologies: A Technicaland Clinical Review (Tuesday)
LL-NM3108-D Nuclear Medicine Assessment of Non-Target OrganResponse to Oncology Therapy (Monday)
LL-NM3109 Role of I-131 SPECT/CT in Addition toPlanar Imagingin the Assessment of Differentiated Thyroid CancerPost I-131 Ablation
LL-NM3110 Organs They Never Taught You about in Bone ScanSchool: Localization and Significance of NonosseousNonurologic Uptake Observed during BoneScintigraphy
Scientific PostersCME is available when the author is present for discussion during thelunch period. Days are listed in parentheses.
Space No. Title
LL-MI2001-B01 Development of 13C Chemical Shift MR Iimaging forthe Depiction of Gliomas Enriched with 13C-LabeledMethionine at 4.7T (Sunday)
LL-MI2002-B02 Diagnostic Role of 3T Diffusion-weighted WholeBody Magnetic Resonance in Staging Hodgkin's andNon-Hodgkin's Lymphoma: Comparison with F18-FDG PET-CT (Sunday)
LL-MI2003-D01 Equivalent Cross Relaxation Rate Imaging for EarlyPrediction of Response to NeoadjuvantChemotherapy in Breast Cancer (Monday)
LL-MI2004-D02 Longitudinal Cellular Imaging of B Cell DepletionTherapy in Vivo (Monday)
LL-MI2005-H01 Microdosing Study for Evaluating Pharmacokinetics(PK) by Means of Planar Positron Imaging System(PPIS): A Comparison between Microdose andTherapeutic Dose PK of Antiepileptic Drug 11C-diphenyl hydantoin (DPH) in Rats (Tuesday)
LL-MI2006-H02 Imaging of Neural Progenitor Cell Homing toNonneural Tumors (Tuesday)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 8
LL-MI2007-L01 Monitoring ER Stress in the Micro-Environments ofSpontaneous Tumors as a Predictor for TumorGrowth (Wednesday)
LL-MI2008-L02 In Vivo Bioluminescence Imaging: Monitoring of theTumor Protective Protein Hypoxia Inducible Factor-1α in Response to Conventional and Low DoseMetronomic Chemotherapy (Wednesday)
LL-MI2009-R01 Multiparametric MR Imaging for AntiangiogenicTumor Treatment Monitoring: A Preclinical Study(Thursday)
LL-MI2010-R02 Cellular Imaging Using Equivalent Cross RelaxationRate Technique in Rabbit VX-2 Tumor Model(Thursday)
LL-NM2011-B01 Differential Diagnosis and Assessment of Prognosisin Malignant Pleural Mesothelioma with 18F-FDG-PET (Sunday)
LL-NM2012-B02 Application of 18F-FDG PET/CT Imaging in SoftTissue Metastasis (Sunday)
LL-NM2013-B03 Nonpalpable Beast Cancer Lesion Excision: AComparison between Radioguide Occult LesionLocatization (ROLL) vs Wire Guide Lumpectomy(WGL) (Sunday)
LL-NM2014-B04 Evaluation of Neuroinflammation in ExperimentalAutoimmune Encephalomyelitis Mice with MicroPositron Emission Tomography and Micro MagneticResonance Imaging (Sunday)
LL-NM2015-B05 PET Manifestation in Different Pathology in Epilepsy(Sunday)
LL-NM2016-B06 SPECT-CT Imaging in the Assessment of Non-specific Foot and Ankle Pain (Sunday)
LL-NM2017-B07 Prospective Semiquantitative Analysis on FDG PET-CT Imaging Features before, 3, and 6 Months afterRFA of Lung Tumors (Sunday)
LL-NM2018-B08 F-18 FDG PET/CT Imaging of Myeloma (Sunday)
LL-NM2019-D01 Is Heart Rate a Risk Factor for Coronary Disease?(Monday)
LL-NM2020-D02 Comparison of Indine-123-metaionidobenzylguanidine Scintigram withContrast-enhanced MR Imaging for Detection ofMyocardial Damage in Patients with DilatedCardiomyopathy (Monday)
LL-NM2021-D03 A Study to Obtain the Reliability of the SUV inPET/CT Systems (Monday)
LL-NM2022-D04 Accuracy and Usefulness of 99mTc-SestamibiSPECT/CT in the Localisation of ParathyroidAbnormalities: Surgical and Histological Correlation(Monday)
LL-NM2023-D05 Ovarian and Endometrial 18F-FDG Uptake during theMenstrual Cycle in Normal Premenopausal Patients:Evaluation by PET/CT (Monday)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 9
LL-NM2024-D06 Comparison of FDG Uptake with PathologicalParameters in the Well-differentiated Thyroid Cancer(Monday)
LL-NM2025-H01 Characterization of Damaged Myocardium in AcuteMyocardial Infarction Using Gated MyocardialPerfusion Single-photon Emission ComputedTomography (SPECT) and Cardiac MagneticResonance Imaging (CMR) (Tuesday)
LL-NM2026-H02 Thyroid Cancer in Toxic Thyroid Nodules: CaseReport and Review of the Literature (Tuesday)
LL-NM2027-H03 Can Calcification Predict 131 Accumulation onMetastatic Lymph Nodes in Papillary ThyroidCarcinoma Patients Receiving I-131 Therapy?Comparison among CT, I -131 WBS, and F-18 FDGPET/CT (Tuesday)
LL-NM2028-H04 Incidence of False Positive Chest Uptake on Indium-labeled Pentetreotide (OctreoScan) for SuspectedNeuroendocrine Tumors (Tuesday)
LL-NM2029-H05 Incidental Parotid Uptake on FDG PET/CT:Frequency and Relevance (Tuesday)
LL-NM2030-L01 Association of Vascular FDG Uptake with Aorta andCarotid Artery in Patients with Aortic Aneurysm(Wednesday)
LL-NM2031-L02 Can 99mTc-sestamibi Thyroid Scintigraphy Make theDifference in the Differential Diagnosis ofAmiodarone-induced Thyrotoxicosis? (Wednesday)
LL-NM2032-L03 Comparative Benefit of CT Scan and Total BodyFDG-PET in the Follow-up of Patients withDifferentiated Thyroid Cancer with Negative Post-therapy 131I-WBS and Serum Tg Levels Detectable(Persistence of Disease) (Wednesday)
LL-NM2033-L04 Comparison of I-123 IMP SPECT, F-18 FDG PET/CT,and F-18 Dopa PET/CT in Detection of UvealMalignant Melanoma (Wednesday)
LL-NM2034-L05 Usefulness of 18F-Fluoride PET/CT in BoneMetastasis of Prostate Cancer (Wednesday)
LL-NM2035-L06 Clinical FDG PET CT in the Investigation ofSuspected Inflammatory and Infective Conditions(Wednesday)
LL-NM2036-R01 A Technique for Reducing the Influence of ScatteredRays from Surrounding Organs to the Heart duringGated Cardiac Blood Pool Scan (Thursday)
LL-NM2037-R02 F-18 FDG PET/CT in Pancreatic Tumors: Is theDifferential Diagnosis between Pancreatic Cancerand Mass-forming Pancreatitis Possible? (Thursday)
LL-NM2038-R03 Correlation of ENT1, TK1, dNT, TMPK, and PCNAExpressions with F-18 FLT Uptake in ColorectalCancer (Thursday)
LL-NM2039-R04 Lymphoscintigraphy as a Useful Method in the Studyof Young Patients with Oedemas and CongenitalPathology Associated Malformations (Thursday)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 10
LL-NM2040-R05 Accuracy of FDG-PET/CT in the Mediastinic Stagingof Patients with Non Small Cell Lung Cancer(NSCLC) (Thursday)
LL-NM2041-R06 [18F]FDG-PET/CT Diagnosis of RecurrentIntraabdominal Cancer in Asymptomatic Patientswith Elevated Tumor Marker Serum Levels andNegative Findings on Conventional Imaging Tests(Thursday)
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 11
RSNA SSC Molecular Imaging 5605:Molecular Imaging 10/26/09 1:43 PM Page 12